Serum liver enzymes are associated with all-cause mortality in an elderly population

Abnormal liver tests in people aged 75 and above: prevalence and association with mortality

(2011) K. M. Fleming et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Rotterdam Study: 2012 objectives and design update

(2011) Albert Hofman et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort

(2011) Matthew J. Armstrong et al.   JOURNAL OF HEPATOLOGY

Body-Mass Index and Mortality among 1.46 Million White Adults

(2010) Amy Berrington de Gonzalez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular Mortality

(2009) Marcello Tonelli et al.   CIRCULATION

Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey

(2009) Duk-Hee Lee et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes

(2008) S.G. Wannamethee et al.   ATHEROSCLEROSIS

Elevated Serum Alanine Aminotransferase and γ-Glutamyltransferase and Mortality in the United States Population

(2008) Constance E. Ruhl et al.   GASTROENTEROLOGY

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease

(2008) Janus P. Ong et al.   JOURNAL OF HEPATOLOGY

Role for alkaline phosphatase as an inducer of vascular calcification in renal failure?

(2008) M. Schoppet et al.   KIDNEY INTERNATIONAL

Impact of Fatty Liver Disease on Health Care Utilization and Costs in a General Population: A 5-Year Observation

(2007) Sebastian E. Baumeister et al.   GASTROENTEROLOGY